|
Financial Information Relating to Reportable Segments (Detail) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2011
|
Dec. 31, 2010
|
|
| Segment Reporting Information [Line Items] | ||||
| External sales | $ 74,662 | $ 67,708 | $ 152,258 | $ 135,653 |
| Earnings before income taxes | 37,873 | 37,673 | 78,373 | 76,626 |
|
Biotechnology
|
||||
| Segment Reporting Information [Line Items] | ||||
| External sales | 69,808 | 63,080 | 142,111 | 126,121 |
| Earnings before income taxes | 37,878 | 37,953 | 77,862 | 76,413 |
|
Hematology
|
||||
| Segment Reporting Information [Line Items] | ||||
| External sales | 4,854 | 4,628 | 10,147 | 9,532 |
| Earnings before income taxes | 1,681 | 1,427 | 3,599 | 3,349 |
|
Reportable Segment
|
||||
| Segment Reporting Information [Line Items] | ||||
| Earnings before income taxes | 39,559 | 39,380 | 81,461 | 79,762 |
|
Unallocated Amount to Segment
|
||||
| Segment Reporting Information [Line Items] | ||||
| Earnings before income taxes | $ (1,686) | $ (1,707) | $ (3,088) | $ (3,136) |